Improvement of Dysgeusia by Polaprezinc, a Zinc-L-carnosine, in Outpatients Receiving Cancer ChemotherapyHironori Fujii, Akio Suzuki, Hisashi Imai et al.|Anticancer Research|2018Cited by 31
A Phase Ⅱ Study of Ubenimex Combined With Pembrolizumab, Nab-Paclitaxel, and Carboplatin for Previously Untreated Advanced Squamous Non–Small-Cell Lung Cancer: TORG2241 (UBE-Q)Shinji Nakamichi, Hiroaki Okamoto, Kaoru Kubota et al.|Clinical Lung Cancer|2023Cited by 6